Tg(tetO/Prnp-MAPT*P301L,-luc)Y74Dbo
Transgene Detail
|
Symbol: |
Tg(tetO/Prnp-MAPT*P301L,-luc)Y74Dbo |
Name: |
transgene insertion Y74, David R Borchelt |
MGI ID: |
MGI:5615836 |
Synonyms: |
TUL-Y74 |
Transgene: |
Tg(tetO/Prnp-MAPT*P301L,-luc)Y74Dbo Location: unknown
|
Alliance: |
Tg(tetO/Prnp-MAPT*P301L,-luc)Y74Dbo page
|
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inducible, Reporter) |
Inducer: |
|
doxycycline/tetracycline |
Mutation: |
|
Insertion
|
|
|
Mutation details: The transgenic construct includes a Tet-responsive element (TRE) and exons 1-2 (non-coding) from the mouse prion protein upstream of a Tau-Ubiquitin-Luciferase (TUL) cDNA sequence, followed by mouse prion protein exon 3 (non-coding) and polyadenylation signal. The TUL cDNA sequence encodes a mutant human tau-P301L with C-terminal ubiquitin, followed by a luciferase gene.
(J:101977, J:234694)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:234694 Fromholt S, et al., Generation of a new transgenic mouse model for assessment of tau gene silencing therapies. Alzheimers Res Ther. 2016;8:36 |
All: |
2 reference(s) |
|